drugset / Trial / NCT00406172
Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
Non-randomizedSingle-groupOpen-label
Summary
To report safety and efficacy of intravitreal injection of bevacizumab in patients with cystoid macular edema secondary to cataract surgery.
Timeline
- Start
- 2006-11
- Primary completion
- 2006-11
- Completion
- 2006-11
Outcome
Outcome not reported
Stopped (Enrollment): “Poor accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | — | Intravitreal |